You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal ⊕

found 2026 › Apr › 27 (Mon) @ 02:19 UTC

Indian ■■
Sun Pharma ■■
US ■■■■
Organon ■■
Sun Pharmaceutical Industries ■■
New ■■

To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.